$CATX
Perspective Therapeutics, Inc.

2014 Q1 Form 10-Q Financial Statement

#000114420414009735 Filed on February 14, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2012 Q4
Revenue $1.134M $1.085M $975.5K
YoY Change -9.36% 11.27% -20.61%
Cost Of Revenue $1.083M $1.119M $1.134M
YoY Change 1.67% -1.3% 10.13%
Gross Profit $50.91K -$33.91K -$158.6K
YoY Change -72.62% -78.63% -179.75%
Gross Profit Margin 4.49% -3.12% -16.26%
Selling, General & Admin $886.3K $840.4K $791.7K
YoY Change 3.67% 6.16% -1.2%
% of Gross Profit 1741.03%
Research & Development $153.6K $170.0K $149.2K
YoY Change -0.98% 13.98% -21.35%
% of Gross Profit 301.75%
Depreciation & Amortization $170.0K $180.0K $180.0K
YoY Change -5.56% 0.0% -21.74%
% of Gross Profit 333.95%
Operating Expenses $1.040M $1.010M $940.8K
YoY Change 2.96% 7.4% -5.06%
Operating Profit -$989.0K -$1.044M -$1.099M
YoY Change 20.01% -5.01% 38.81%
Interest Expense $86.00 -$50.00K
YoY Change -100.17% -131.25%
% of Operating Profit
Other Income/Expense, Net -$1.094M $117.4K -$54.87K
YoY Change -1103.31% -313.94% -133.6%
Pretax Income -$2.080M -$930.0K -$1.150M
YoY Change 188.89% -19.13% 82.54%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.083M -$927.0K -$1.154M
YoY Change 191.37% -19.7% 83.59%
Net Earnings / Revenue -183.67% -85.4% -118.34%
Basic Earnings Per Share
Diluted Earnings Per Share -$48.93K -$24.25K -$33.24K
COMMON SHARES
Basic Shares Outstanding 41.54M shares 38.42M shares 34.60M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q4 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.70M $4.410M $4.440M
YoY Change 544.02% -0.68% 31.36%
Cash & Equivalents $23.70M $4.415M $4.441M
Short-Term Investments
Other Short-Term Assets $210.0K $160.0K $230.0K
YoY Change 0.0% -30.43% 91.67%
Inventory $387.0K $426.3K $402.9K
Prepaid Expenses
Receivables $805.3K $917.2K $656.2K
Other Receivables $0.00 $10.00K $0.00
Total Short-Term Assets $25.11M $5.925M $5.736M
YoY Change 393.03% 3.28% 11.17%
LONG-TERM ASSETS
Property, Plant & Equipment $1.183M $1.349M $2.029M
YoY Change -36.15% -33.48% -27.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $258.6K $262.7K $301.1K
YoY Change -11.91% -12.75% 30.9%
Total Long-Term Assets $2.093M $2.263M $2.981M
YoY Change -25.2% -24.07% -9.4%
TOTAL ASSETS
Total Short-Term Assets $25.11M $5.925M $5.736M
Total Long-Term Assets $2.093M $2.263M $2.981M
Total Assets $27.20M $8.188M $8.717M
YoY Change 244.74% -6.07% 3.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $610.0K $430.0K $390.0K
YoY Change 64.86% 10.26% 11.43%
Accrued Expenses $410.0K $420.0K $300.0K
YoY Change 46.43% 40.0% -26.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.021M $847.3K $696.8K
YoY Change 57.21% 21.59% -8.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.530M $850.0K $1.000M
YoY Change 68.13% -15.0% -0.99%
Total Long-Term Liabilities $1.530M $850.0K $1.000M
YoY Change 68.13% -15.0% -0.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.021M $847.3K $696.8K
Total Long-Term Liabilities $1.530M $850.0K $1.000M
Total Liabilities $2.546M $1.699M $1.694M
YoY Change 63.74% 0.27% -4.28%
SHAREHOLDERS EQUITY
Retained Earnings -$56.37M -$54.29M -$50.38M
YoY Change 10.32% 7.75%
Common Stock $54.18K $38.42K $34.61K
YoY Change 56.54% 11.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.390K $8.390K $8.390K
YoY Change 0.0% 0.0%
Treasury Stock Shares 13.20K shares 13.20K shares $13.20K
Shareholders Equity $24.65M $6.489M $7.022M
YoY Change
Total Liabilities & Shareholders Equity $27.20M $8.188M $8.717M
YoY Change 244.74% -6.07% 3.16%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2012 Q4
OPERATING ACTIVITIES
Net Income -$2.083M -$927.0K -$1.154M
YoY Change 191.37% -19.7% 83.59%
Depreciation, Depletion And Amortization $170.0K $180.0K $180.0K
YoY Change -5.56% 0.0% -21.74%
Cash From Operating Activities -$500.0K -$850.0K -$570.0K
YoY Change -34.21% 49.12% 21.28%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$20.00K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 -$20.00K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 19.79M -10.00K -10.00K
YoY Change 0.0% -100.44%
NET CHANGE
Cash From Operating Activities -500.0K -850.0K -570.0K
Cash From Investing Activities 0.000 -20.00K 0.000
Cash From Financing Activities 19.79M -10.00K -10.00K
Net Change In Cash 19.29M -880.0K -580.0K
YoY Change -2638.16% 51.72% -132.4%
FREE CASH FLOW
Cash From Operating Activities -$500.0K -$850.0K -$570.0K
Capital Expenditures $0.00 -$20.00K $0.00
Free Cash Flow -$500.0K -$830.0K -$570.0K
YoY Change -34.21% 45.61% 23.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000728387
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
41540982 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
IsoRay, Inc.
isr Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
5648738 shares
CY2013Q3 isr Gross Proceeds From Issuance Of Stock
GrossProceedsFromIssuanceOfStock
3703527 USD
CY2013Q3 isr Payments For Underwriting Fees Costs
PaymentsForUnderwritingFeesCosts
185176 USD
CY2013Q3 isr Payments Of Stock Issuance Costs Legal And Accounting Expense
PaymentsOfStockIssuanceCostsLegalAndAccountingExpense
184514 USD
isr Class Of Warrant Or Right Issued In Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightIssuedInPeriodExercisePriceOfWarrantsOrRights
0.72
CY2013Q3 isr Payments Of Stock Issuance Costs Listing Expense
PaymentsOfStockIssuanceCostsListingExpense
48500 USD
CY2013Q3 isr Payments Of Stock Issuance Costs Other Expenses
PaymentsOfStockIssuanceCostsOtherExpenses
6045 USD
isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
20083 USD
isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
13477 USD
CY2013Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
432566 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
430293 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
923780 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
917222 USD
CY2013Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
107578 USD
CY2013Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
104932 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
57431293 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
60747935 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
15371 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
14024 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
51784 USD
CY2013Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13432 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
57789 USD
CY2012Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28826 USD
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
52598 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32515 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13156388 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4328170 shares
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
36326 USD
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
33211 USD
CY2013Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
792242 USD
CY2013Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
828568 USD
CY2013Q2 us-gaap Assets
Assets
7055356 USD
CY2013Q4 us-gaap Assets
Assets
8187662 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
4443660 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
5924556 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2672711 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2899927 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4414572 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4440703 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1514645 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1767992 USD
CY2013Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.38
CY2013Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.89
CY2013Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1957033 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7605771 shares
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
193000000 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192998329 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34618517 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38419502 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34618517 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38419502 shares
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
34618 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
38420 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
2246537 USD
CY2013Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1119314 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
2210740 USD
CY2012Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1134083 USD
CY2013Q3 us-gaap Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued
DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
25150 USD
CY2013Q3 us-gaap Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued
DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
6906 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
349232 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
388171 USD
CY2013Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
104000 USD
CY2013Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
23000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <table style="MARGIN-BOTTOM: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-TOP: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify"> <td style="WIDTH: 0px">&nbsp;</td> <td style="WIDTH: 0.5in; TEXT-ALIGN: left"><strong>2.</strong></td> <td style="TEXT-ALIGN: justify"><strong>New Accounting Pronouncements</strong></td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>&nbsp;</strong></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the "FASB") or other standards setting bodies that are adopted by us as of the specified effective dates. Unless otherwise discussed, we believe the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position, results of operations and cash flows upon adoption.</p> <!--EndFragment--></div> </div>
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
127419 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
141082 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P9M26D
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
42626 USD
CY2013Q4 us-gaap Gross Profit
GrossProfit
-33906 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1165000 USD
CY2013Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
513964 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1114412 USD
CY2012Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
469559 USD
us-gaap Gross Profit
GrossProfit
-111214 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
13750 USD
us-gaap Gross Profit
GrossProfit
-179051 USD
CY2012Q4 us-gaap Gross Profit
GrossProfit
-158626 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2273 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4120 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-26641 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-222365 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
13663 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
9181 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20762 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-41433 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
21668 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
24000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
24000 USD
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-2646 USD
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-3230 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1438 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1914 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-46515 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
84252 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
32 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
84 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
827 USD
CY2013Q4 us-gaap Interest And Debt Expense
InterestAndDebtExpense
86 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
6 USD
CY2012Q4 us-gaap Interest And Debt Expense
InterestAndDebtExpense
USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
426333 USD
CY2013Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
469758 USD
CY2013Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
469758 USD
CY2013Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
167671 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
168731 USD
CY2013Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
195323 USD
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
212726 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3294479 USD
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
42577 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
44876 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
405571 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
835 USD
CY2013Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
481 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
272 USD
CY2012Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
128 USD
CY2013Q2 us-gaap Liabilities
Liabilities
1689110 USD
CY2013Q4 us-gaap Liabilities
Liabilities
1698848 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7055356 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8187662 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
792868 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
847280 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3268660 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-16013 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-13491 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1738002 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1512996 USD
us-gaap Net Income Loss
NetIncomeLoss
-2197878 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-926972 USD
us-gaap Net Income Loss
NetIncomeLoss
-2147995 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-1154327 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2929572 USD
CY2013Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-929630 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2153311 USD
CY2012Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1156985 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
81008 USD
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
117395 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
74266 USD
CY2012Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-54872 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
46973 USD
us-gaap Operating Expenses
OperatingExpenses
2167672 USD
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
1010461 USD
us-gaap Operating Expenses
OperatingExpenses
2043210 USD
CY2012Q4 us-gaap Operating Expenses
OperatingExpenses
940829 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2278886 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1044367 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2222261 USD
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1099455 USD
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
25305 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
276507 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
262698 USD
CY2013Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
100000 USD
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
124000 USD
CY2013Q2 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
11502 USD
CY2013Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
10064 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
10632 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
10632 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1562 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
13407 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14419 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5316 USD
CY2013Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2658 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5316 USD
CY2012Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2658 USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
726378 USD
CY2013Q4 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
USD
us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
USD
CY2012Q4 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
USD
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671 shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
59 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
61 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
202880 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
156365 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3291977 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1478712 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1800580 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
USD
CY2013Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3279292 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11309 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1825 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1684282 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1349469 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
317020 USD
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
170030 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
290648 USD
CY2012Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
149176 USD
CY2013Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181149 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181181 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-52091334 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54289212 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2135323 USD
CY2013Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1085408 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2031689 USD
CY2012Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
975457 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
114801 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2278260 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.84
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y6M
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.58
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.59
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
5366246 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
6488814 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
31700 shares
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
13200 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
13200 shares
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
8390 USD
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
8390 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
81000 USD
CY2013Q4 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
117000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
74000 USD
CY2012Q4 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-55000 USD
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
23000 USD
CY2012Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
240000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37133875 shares
CY2013Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38419502 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34238401 shares
CY2012Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34604605 shares
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
685652 USD
CY2013Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
326467 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
638150 USD
CY2012Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
322094 USD
us-gaap Share Based Compensation
ShareBasedCompensation
51786 USD
us-gaap Share Based Compensation
ShareBasedCompensation
57789 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.58
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.59
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.3231 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.3231 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0185 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0177 pure
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2080064 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.90
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
13866 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
15000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
65000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
125884 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2370072 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.79
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y6M26D
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
125784 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y1M17D

Files In Submission

Name View Source Status
0001144204-14-009735-index-headers.html Edgar Link pending
0001144204-14-009735-index.html Edgar Link pending
0001144204-14-009735.txt Edgar Link pending
0001144204-14-009735-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
isr-20131231.xml Edgar Link completed
isr-20131231.xsd Edgar Link pending
isr-20131231_cal.xml Edgar Link unprocessable
isr-20131231_def.xml Edgar Link unprocessable
isr-20131231_lab.xml Edgar Link unprocessable
isr-20131231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v367032_10q.htm Edgar Link pending
v367032_ex31-1.htm Edgar Link pending
v367032_ex31-2.htm Edgar Link pending
v367032_ex32.htm Edgar Link pending